Evidence map›Paper›PMID 30023348›Full record

ArticleEuropean thyroid journal2018

Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience.

Marie Alix Balay, Patrick Aidan, Marie Helene Schlageter, Odette Georges, Taly Meas, Maroun Bechara, Marie Elisabeth Toubert, Isabelle Faugeron, Herve Monpeyssen, Cécile N Chougnet

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European thyroid journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Marie Alix BalayHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Patrick AidanAmerican Hospital of Paris, Neuilly sur Seine, France.
Marie Helene SchlageterHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Odette GeorgesAmerican Hospital of Paris, Neuilly sur Seine, France.
Taly MeasHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Maroun BecharaAmerican Hospital of Paris, Neuilly sur Seine, France.
Marie Elisabeth ToubertHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Isabelle FaugeronHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Herve MonpeyssenAmerican Hospital of Paris, Neuilly sur Seine, France.
Cécile N ChougnetHôpital Saint Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Assistance Publique – Hôpitaux de Paris · FRHôpital américain de paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTransaxillary robotic thyroidectomy surgery (TARS) has been reported to be a safe approach in patients with differentiated thyroid carcinoma, and oncological responses are promising. STUDY

designThis study aimed to evaluate the oncological outcomes of TARS followed by radioiodine (RAI) therapy in patients with differentiated thyroid carcinoma. Between 2011 and 2016, patients treated for differentiated thyroid carcinoma by TARS in a single institution, followed by RAI, were retrospectively included. The oncological response was performed according to the 2015 American Thyroid Association (ATA) guidelines 6-12 months later and at the last available visit.

resultsA total of 42 patients (30 females) were included, with a median tumor size of 20 mm (12 cases of N1a and 5 cases of N1b on initial pathology report). According to ATA classification of recurrence risk after surgery, 17 and 25 patients were classified as low and intermediate risk, respectively. After RAI, all patients had a normal posttherapeutic whole body scan (except 1 patient, who had pathological lymph node uptake), but no unusual uptake was seen. At the 6- to 12-month evaluation (

conclusionIn this study, TARS followed by RAI therapy seems to be curative, even for patients with lymph node metastases, after good preoperative staging. More studies are required to confirm the findings.

Indexed as

CancerDifferentiated thyroid cancerOncological evaluationPapillary thyroid carcinomaQuality of lifeRadioiodine ablationRadioiodine therapyRobotic surgerySurgeryThyroid cancer

Identifiers

PMID30023348
PMCPMC6047495
OpenAlexW2788098402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.